Alan S. Premasiri, Anna L. Gill, & Fernando G. Vieira. (2020). Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity. Frontiers Media S.A..
Chicago Style (17th ed.) CitationAlan S. Premasiri, Anna L. Gill, and Fernando G. Vieira. Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity. Frontiers Media S.A., 2020.
MLA (9th ed.) CitationAlan S. Premasiri, et al. Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity. Frontiers Media S.A., 2020.
Warning: These citations may not always be 100% accurate.